Application of machine learning approaches for predicting hemophilia A severity

被引:4
作者
Rawal, Atul [1 ]
Kidchob, Christopher [1 ]
Ou, Jiayi [1 ]
Sauna, Zuben E. [1 ]
机构
[1] US FDA, Ctr Biol Evaluat & Res, Div Plasma Prot Therapeut, Hemostasis Branch, Silver Spring, MD 20993 USA
关键词
antidrug antibodies; artificial intelligence (AI); hemophilia A; immunogenicity; machine learning; severity; FACTOR-VIII; WOMEN; NOMENCLATURE; INHIBITOR; PHENOTYPE; CARRIER;
D O I
10.1016/j.jtha.2024.04.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hemophilia A (HA) is an X-linked congenital bleeding disorder, which leads to deficiency of clotting factor (F) VIII. It mostly affects males, and females are considered carriers. However, it is now recognized that variants of F8 in females can result in HA. Nonetheless, most females go undiagnosed and untreated for HA, and their bleeding complications are attributed to other causes. Predicting the severity of HA for female patients can provide valuable insights for treating the conditions associated with the disease, such as heavy bleeding. Objectives: To predict the severity of HA based on F8 genotype using a machine learning (ML) approach. Methods: Using multiple datasets of variants in the F8 and disease severity from various repositories, we derived the sequence for the FVIII protein. Using the derived sequences, we used ML models to predict the severity of HA in female patients. Results: Utilizing different classification models, we highlight the validity of the datasets and our approach with predictive F1 scores of 0.88, 0.99, 0.93, 0.99, and 0.90 for all the validation sets. Conclusion: Although with some limitations, ML-based approaches demonstrated the successful prediction of disease severity in female HA patients based on variants in the F8. This study confirms previous research findings that ML can help predict the severity of hemophilia. These results can be valuable for future studies in achieving better treatment and clinical outcomes for female patients with HA, which is an urgent unmet need.
引用
收藏
页码:1909 / 1918
页数:10
相关论文
共 28 条
[1]   Factor 8 Gene Mutation Spectrum of 270 Patients with Hemophilia A: Identification of 36 Novel Mutations [J].
Atik, Tahir ;
Isik, Esra ;
Onay, Huseyin ;
Akgun, Bilcag ;
Shamsali, Moharram ;
Kavaklo, Kaan ;
Evim, Melike ;
Tuysuz, Gulen ;
Ozbek, Namik Yasar ;
Sahin, Fahri ;
Salcioglu, Zafer ;
Albayrak, Canan ;
Oymak, Yesim ;
Unal, Ekrem ;
Belen, Fatma Burcu ;
Yilmaz, Ebru ;
Balkan, Can ;
Baytan, Birol ;
Kupesiz, Alphan ;
Culha, Vildan ;
Gucer, Tuba Nur Tahtakesen ;
Gunes, Adalet Meral ;
Ozkinay, Ferda .
TURKISH JOURNAL OF HEMATOLOGY, 2020, 37 (03) :145-153
[2]   POINTS OF SIGNIFICANCE Statistics versus machine learning [J].
Bzdok, Danilo ;
Altman, Naomi ;
Krzywinski, Martin .
NATURE METHODS, 2018, 15 (04) :232-233
[3]   Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A [J].
Carcao, Manuel D. ;
van den Berg, H. Marijke ;
Ljung, Rolf ;
Mancuso, Maria Elisa .
BLOOD, 2013, 121 (19) :3946-3952
[4]   The current role of artificial intelligence in hemophilia [J].
Carlos Rodriguez-Merchan, E. .
EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (10) :927-931
[5]   Challenges and knowledge gaps facing hemophilia carriers today: Perspectives from patients and health care providers [J].
Chaigneau, Megan ;
Botros, Monique ;
Grabell, Julie ;
Hopman, Wilma ;
James, Paula .
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (06)
[6]   Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative [J].
Johnsen, Jill M. ;
Fletcher, Shelley N. ;
Huston, Haley ;
Roberge, Sarah ;
Martin, Beth K. ;
Kircher, Martin ;
Josephson, Neil C. ;
Shendure, Jay ;
Ruuska, Sarah ;
Koerper, Marion A. ;
Morales, Jaime ;
Pierce, Glenn F. ;
Aschman, Diane J. ;
Konkle, Barbara A. .
BLOOD ADVANCES, 2017, 1 (13) :824-834
[7]   HemoBase: A multidisciplinary registration systeem in hemato-oncology. [J].
Joosten, Peter ;
Hoogendoorn, Mels ;
Storm, Huib ;
Kibbelaar, Robby E. .
BLOOD, 2006, 108 (11) :473B-474B
[8]   A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model [J].
Kitazawa, Takehisa ;
Igawa, Tomoyuki ;
Sampei, Zenjiro ;
Muto, Atsushi ;
Kojima, Tetsuo ;
Soeda, Tetsuhiro ;
Yoshihashi, Kazutaka ;
Okuyama-Nishida, Yukiko ;
Saito, Hiroyuki ;
Tsunoda, Hiroyuki ;
Suzuki, Tsukasa ;
Adachi, Hideki ;
Miyazaki, Taro ;
Ishii, Shinya ;
Kamata-Sakurai, Mika ;
Iida, Takeo ;
Harada, Aya ;
Esaki, Keiko ;
Funaki, Miho ;
Moriyama, Chifumi ;
Tanaka, Eriko ;
Kikuchi, Yasufumi ;
Wakabayashi, Tetsuya ;
Wada, Manabu ;
Goto, Masaaki ;
Toyoda, Takeshi ;
Ueyama, Atsunori ;
Suzuki, Sachiyo ;
Haraya, Kenta ;
Tachibana, Tatsuhiko ;
Kawabe, Yoshiki ;
Shima, Midori ;
Yoshioka, Akira ;
Hattori, Kunihiro .
NATURE MEDICINE, 2012, 18 (10) :1570-U177
[9]  
Lee C.A., 2011, Textbook of hemophilia
[10]   A Machine Learning Framework Predicts the Clinical Severity of Hemophilia B Caused by Point-Mutations [J].
Lopes, Tiago J. S. ;
Nogueira, Tatiane ;
Rios, Ricardo .
FRONTIERS IN BIOINFORMATICS, 2022, 2